Revolution Medicines stock soared Monday on what the company called "unprecedented" test results for its pancreatic cancer treatment.
Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we ... [1013 chars]